Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide Dose-Finding in Japanese T2D
NCT00154414Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Jan 2005
- Primary completion
- May 2006
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of liraglutide in type 2 diabetes mellitus (T2DM) (5 arms), sponsored by Novo Nordisk. Primary endpoint: Glycated Hemoglobin A1c at 14 weeks. Started Jan 2005; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00154414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00154414.